Diagnostic Imaging (5/12) reported that research suggests “adding digital breast tomosynthesis to conventional 2D screening mammography improves reading specificity, particularly for radiologists with less than 10 years experience.” The findings were published in Radiology.
Medscape (5/10, Hein) reports that research suggests “radiology subspecialists can detect breast cancers missed on initial screenings in people not diagnosed with breast cancer.” The findings were presented at the American Roentgen Ray Society 2017 Annual Meeting.
Forbes (5/8): You may have heard that some breast cancers vanish without treatment. Last month, a group of radiologists published results of a survey in the Journal of the American College of Radiology. The findings from 42 experts who responded are striking.
Of 240 invasive breast cancers found by screening that went untreated, zero (0) went away. Of 239 noninvasive cases (DCIS), zero (0) regressed, as reported by the breast imaging specialists in a survey. In sum, 0 of 479 untreated breast tumors disappeared without treatment, according to the radiologists who participated.
DOT Med News (5/5, Mitchell) reported that “the American College of Radiology (ACR) has published evidence refuting the assertion that breast cancer regresses or disappears if left untreated.” The findings were published in the Journal of the American College of Radiology. Dr. Debra Monticciolo, chair of the ACR Breast Imaging Commission, said, “The USPSTF states that a large part of the reason that they do not recommend screening in women under age 50, and recommend biennial rather than annual screening, is to decrease overdiagnosis. Several authors, notably Gilbert Welch, have stated that much overdiagnosis is due to cancers disappearing on their own.” Dr. Monticciolo added, “Our research shows that this is untrue.” Forbes (5/8, Schattner) provides additional coverage.